Free download account of killexams.com OCN exam dumps

At killexams.com, we surrender substantial and to date Medical OCN genuine Questions and Answers that are as of later needed for the Passing OCN test. We truly enable individuals to further develop their insight to answer Oncology Certified Nurse - 2022 practice questions and pass-ensure. It is a most ideal decision to speed up your situation as a specialist in your Organization.

Exam Code: OCN Practice test 2022 by Killexams.com team
OCN Oncology Certified Nurse - 2022

Exam ID : OCN
Exam Title : Oncology Certified Nurse (OCN®)
Questions : 165
Duration : 3 hours
Exam Type : multiple-choice

Test Content Outline (Effective 2020)
I. Care Continuum - 19%
A. Health promotion and disease prevention (e.g., high-risk behaviors; preventive health practices)
B. Screening and early detection
C. Navigation
D. Advance care planning (e.g., advance directives)
E. Epidemiology
1. Modifiable risk factors (e.g., smoking, diet, exercise, occupation)
2. Non-modifiable risk factors (e.g., age, gender, genetics)
F. Survivorship
1. Rehabilitation
2. Recurrence concerns
3. Financial concerns
4. Employment concerns
5. Insurance concerns
6. Family and social support concerns
7. Sexuality concerns
G. Treatment-related considerations
1. Delayed-onset side effects
2. Chronic side effects
3. Secondary malignancies
4. Follow-up care
H. End-of-life care
1. Grief
2. Bereavement
3. Hospice care
4. Caregiver support
5. Interdisciplinary team
6. Pharmacologic comfort measures
7. Non-pharmacologic comfort measures
II. Oncology Nursing Practice - 17 %
A. Scientific basis
1. Carcinogenesis
2. Immunology
3. Clinical trials (e.g., research protocols)
B. Site-specific cancer considerations
1. Pathophysiology
2. Common metastatic locations
3. Diagnostic measures
4. Prognosis
5. Classification
6. Staging
7. Histological grading
C. Scope, standards, and related issues
1. Standards of care (nursing process)
2. Legal (including documentation)
3. Accreditation (e.g., The Joint Commission)
4. Self-care (e.g., managing compassion fatigue)
D. Standards of professional performance
1. Ethics (e.g., patient advocacy)
2. Education
3. Evidence-based practice (e.g., Putting Evidence Into Practice (PEP) guidelines) and research
4. Quality of practice
5. Communication
6. Leadership
7. Collaboration
8. Professional practice evaluation
9. Resource utilization
10. Environmental health (e.g., safety, personal protective equipment, safe handling)
III. Treatment Modalities - 19%
A. Surgery
B. Blood and marrow transplant
C. Radiation therapy
D. Chemotherapy
E. Biotherapy
F. Immunotherapy
G. Vascular Access Devices (VADs) for treatment administration
H. Targeted Therapy
IV. Symptom Management and Palliative Care - 23%
A. Etiology and patterns of symptoms (acute, chronic, late)
B. Anatomical and surgical alterations (e.g., lymphedema, ostomy, site-specific radiation)
C. Pharmacologic interventions
D. Complementary and integrative modalities (e.g., massage, acupuncture, herbal supplements)
E. Palliative care considerations
F. Alterations in functioning
1. Hematologic
2. Immune system
3. Gastrointestinal
4. Genitourinary
5. Integumentary
6. Respiratory
7. Cardiovascular
8. Neurological
9. Musculoskeletal
10. Nutrition
11. Cognition
12. Energy level (i.e., fatigue)
V. Oncologic Emergencies - 12%
A. Disseminated intravascular coagulation (DIC)
B. Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
C. Sepsis (including septic shock)
D. Tumor lysis syndrome
E. Hypersensitivity
F. Anaphylaxis
G. Hypercalcemia
H. Cardiac tamponade
I. Spinal cord compression
J. Superior vena cava syndrome
K. Increased intracranial pressure
L. Obstructions (bowel and urinary)
M. Pneumonitis
N. Extravasations
VI. Psychosocial Dimensions of Care - 10%
A. Cultural, spiritual, and religious diversity
B. Financial concerns (including available resources)
C. Altered body image
D. Learning styles and barriers to learning
E. Social relationships and family dynamics
F. Coping mechanisms and skills
G. Support
1. Patient (i.e., individual and group)
2. Caregiver (including family)
H. Psychosocial considerations
1. Anxiety
2. Loss and grief
3. Depression
4. Loss of personal control
I. Sexuality
1. Reproductive issues (e.g., contraception, fertility)
2. Sexual dysfunction (e.g., physical and psychological effects)
3. Intimacy

Oncology Certified Nurse - 2022
Medical Certified information
Killexams : Medical Certified information - BingNews https://killexams.com/pass4sure/exam-detail/OCN Search results Killexams : Medical Certified information - BingNews https://killexams.com/pass4sure/exam-detail/OCN https://killexams.com/exam_list/Medical Killexams : Benefits of ISO 13485 Certification for Medical Device Manufacturing

The medical device sector must meet stringent regulatory requirements plus convince potential customers that they make reliable, safe products. Having a strong commitment to quality can help customers achieve both those aims and others.

Parts of the ISO 13485 process involve identifying and documenting processes. For example, company representatives must find all processes that have even a minor connection to manufacturing. Next, they must create written procedures to establish which elements could introduce risks to the product.

Those threats could range from contaminated equipment to poorly trained personnel. After bringing attention to the risks, company representatives must name and describe measures to mitigate the potential issues.

ISO 13485 does not spell out the specific measures for device manufacturers to take. However, the certification gets people in the mindset that quality happens at every stage of manufacturing and that ongoing efforts enable maintaining high standards.

Reducing the Likelihood of Longstanding Issues

Another component of ISO 13485 requires ongoing managerial reviews to determine whether previously implemented controls work as expected or if further tweaks would get better results. Unfortunately, some leaders see these evaluations as box-checking exercises and feel under excessive pressure to get them done.

However, gathering relevant data and creating processes to keep that information up-to-date and accessible can make it easier to carry out thorough, non-rushed reviews related to ISO 13485. 

For example, looking at customer feedback, audit results, new regulatory requirements, and any details of corrective actions taken so far can help decision-makers verify whether quality controls related to ISO 13485 have the desired effects.

Additionally, these periodic reviews Boost the chances of catching issues that could lead to faulty products or operational efficiencies. They encourage better visibility that limits the likelihood of an unaddressed issue causing long-term problems.

Increasing Marketplace Competitiveness

The most accurate version of ISO 13485 requires that certified companies insist that any subcontractors conform to the standard, too. That means the commitment to quality extends beyond a particular organization. Many potential customers appreciate that, knowing that working with any new company poses challenges. ISO 13485 reduces many of them with its emphasis on quality.

Also, since ISO 13485 is an internationally recognized standard, it can help in cases where company leaders want to expand into other countries and boost their chances of success. Certification assists organizational leaders in conveying that they take quality seriously.

It’s vital to convince stakeholders of efforts to prioritize quality since medical devices directly affect people’s lives. Minimizing the chances of harm and increasing positive outcomes helps potential customers build trust in a company and decide it makes sense to work with or purchase from them.

Helping Products Stay on the Market Without Issues

Statistics indicate that approximately 4,500 medical devices and drugs get taken off the market owing to recalls. Just as managerial reviews of ISO 13485 processes can prevent persistent issues, a certified company is less likely to experience problems that lead to getting products pulled from shelves. In addition to the lost profits that such events cause, recalls can permanently damage the public’s reputation, making many people perceive a troubled brand as unsafe.

However, corrective and preventive actions get built into the ISO 13485 framework, helping company representatives identify and tackle problems faster than they otherwise might. It’s also advantageous that getting certified can help create and maintain a culture of personal responsibility within the organization.

Once an employee understands that a single missed step or ignored protocol could cause quality issues that affect a whole organization, they’ll likely become more conscious of their behaviors and choices made while working.

Plus, if a company does experience a recall, being ISO 13485-certified should make it easier to target where things went wrong and prevent future issues. Doing those things should bolster public trust and reassure people that a device manufacturer has its operations under control.

ISO 13485 Certifications Strengthens Medical Device Companies

The medical device sector is a high-pressure industry where people praise innovation as long as it doesn’t sacrifice user safety. Moreover, manufacturers must respond to demand spikes, as instances like the surge in ventilator needs during the COVID-19 pandemic showed.

Getting an ISO 13485 certification can help a company make positive, permanent quality and process improvements. Thus, representatives from certified companies often find that ISO 13485 contributes to organizational resilience. It’s not right for every organization, but the associated benefits make it well worth consideration.

Wed, 30 Nov 2022 10:00:00 -0600 en text/html https://www.plasticstoday.com/medical/benefits-iso-13485-certification-medical-device-manufacturing
Killexams : VirtaMed and CICE to announce partnership for gynecological endoscopy certification

The CICE (International Center for Endoscopic Surgery) in Clermont-Ferrand, France, an internationally renowned endoscopic training center and the first in Europe to implement the European certification (GESEA), has inaugurated a training room using VirtaMed LaparoS™ Gynecological Laparoscopy and GynoS™ Hysteroscopy simulators.

CICE and VirtaMed will partner to integrate the VirtaMed mixed-reality simulators into the CICE training program, developing a comprehensive training approach with the goal to include more advanced and measurable surgical cases to Boost the quality of training and the skills transfer to the operating room.

The VR-enabled simulators allow surgeons to practice key surgical skills such as camera navigation, fluid management, safe exposure and resection of anatomical structures as well as handling of surgical complications. All this in a highly realistic, objective and stress-free training environment. 

We are very excited to collaborate with VirtaMed on the development of an advanced surgical training program for gynecology. We chose the VirtaMed simulators because they offer a training environment that is very close to what we experience in the operating room and at the same time it offers objective performance evaluation criteria,”

Professor Revaz Botchorishvili, Director of CICE

"Our team is looking forward to working with CICE. VirtaMed’s simulators are designed with the premise of teaching manual skills based on state-of-the-art learning psychology findings in a highly realistic environment. The collaboration goes well in hand with our efforts towards standardized and proficiency based training not only for novices but also for more advanced residents," explains Dr. Martina Vitz, Senior Vice-President Training and Education at VirtaMed. 

VirtaMed is the world leader in medical training using mixed reality simulators for minimally invasive diagnostic and therapeutic interventions in general surgery, OB/GYN, orthopedics, and urology. Combining virtual reality graphics with original instruments and anatomic models for realistic tactile feedback, VirtaMed partners with medical societies, such as the European Society for Gynecological Endoscopy (ESGE), and medical device companies.  

VirtaMed’s simulation platform offers unique features:

  • Compatibility with all VirtaMed training specialities
  • Possibility to switch between different modules in less than 1 minute
  • Reliability and robustness of Swiss engineering

VirtaMed's vision is to Boost the quality of medical care with state-of- the-art, virtual reality based medical training and education. For more information, visit www.virtamed.com 

Thu, 08 Dec 2022 00:58:00 -0600 en text/html https://www.news-medical.net/news/20221208/VirtaMed-and-CICE-to-announce-partnership-for-gynecological-endoscopy-certification.aspx
Killexams : Medical people: News about medical professionals around Polk County

FOOT AND ANKLE ASSOCIATES OF LAKELAND

Matt Werd © Provided to The Ledger Matt Werd

Matt Werd, DPM, FACFAS, was a featured sports medicine speaker at the national meeting of the American Academy of Podiatric Practice Management held Nov. 3 in Fort Lauderdale. The AAPPM meeting attracts foot and ankle specialists from throughout the United States and internationally. Werd’s lecture syllabu was “Prefab AFOs (Ankle-Foot-Orthoses) to Keep Athletes Active.” He also served as an expert panelist for a question-and-answer session on lower extremity sports injuries. Werd has co-authored two editions of the medical text “Athletic Footwear and Orthoses in Sports Medicine” Springer Publishing 2017.

WATSON CLINIC

D’Aishia Burgess © Provided to The Ledger D’Aishia Burgess

Registered nurse practitioner D’Aishia Burgess works alongside board-certified pulmonology specialist Naem Shahrour, from Watson Clinic Main at 1600 Lakeland Hills Blvd., Lakeland.  Burgess achieved her bachelor's in nursing from Polk State College in Winter Haven and her master's in nursing from Florida Southern College in Lakeland. She is a member of the American Association of Nurse Practitioners and the Florida Association of Nurse Practitioners, and is certified by the American Nurses Credentialing Center. 863-680-7190.

Amanda Porter © Provided to The Ledger Amanda Porter

Physician assistant Amanda Porter serves patients of board-certified orthopedic surgeon Obafunto Abimbola from Watson Clinic Main at 1600 Lakeland Hills Blvd. in Lakeland. She earned a bachelor's in athletic training from the University of Wisconsin Oshkosh in Oshkosh, Wisconsin, a master's in physical education Western Michigan University in Kalamazoo, Michigan, and a master's in health sciences from George Washington University in Washington, D.C. She is a member of the American Academy of Physician Assistants, the Physician Assistants of Orthopaedic Surgery and the Florida Academy of Physician Assistants.  She is certified by the National Commission on Certification of Physician Assistants. 863-680-7214.

Nicole Hamlin © Provided to The Ledger Nicole Hamlin

Registered nurse practitioner Nicole B. Hamlin works alongside board-certified otolaryngologist and facial plastic surgeon Raam S. Lakhani, M.D., from the Watson Clinic Bella Vista Building, 1755 N. Florida Ave., Lakeland. Hamlin earned her bachelor's in nursing from the University of South Florida in Tampa and her master's in nursing from Florida Southern College in Lakeland. She is a member of the American Academy of Nurse Practitioners. 863-904-6296.

Brandi Ray © Provided to The Ledger Brandi Ray

Registered nurse practitioner Brandi C. Ray sees patients of board-certified internal medicine specialist Agustin Tavares from Watson Clinic South, 1033 N. Parkway Frontage Road, Lakeland. Ray earned her bachelor's and master's in nursing from the University of South Florida in Tampa. She is a certified family nurse practitioner by the American Academy of Nurse Practitioners, and is a member of the American Academy of Nurse Practitioners and the American Association of Critical Care Nurses Alumnus. 863-680-7190.

Julian Rios, a registered nurse at Watson Clinic Urgent Care Main, was recently named the recipient of the November Program for Employee Excellence and Recognition award. Rios has been with Watson Clinic for 14 years. Over the course of his career, whether he was providing care to urology patients or as an employee health nurse in our human resources department during COVID, Rios has been admired for his easygoing and friendly nature and for being an exceptional team member. Rios received a plaque, dinner at a local restaurant, a reserved parking spot and a gift certificate from the Medical Spa at Watson Clinic. 

David Graham © Provided to The Ledger David Graham

David Graham, a board-certified radiation oncologist at the Watson Clinic Cancer and Research Center, is the first specialist in Florida to be named a Center of Excellence for his expertise in utilizing the SpaceOAR Hydrogel, an injectable spacer that minimizes the side effects of radiation therapy for prostate cancer patients. This recognition was presented by the device manufacturer Boston Scientific. Radiation therapy can produce undesirable side effects. The SpaceOAR Hydrogel is a soft injectable spacer that gently separates the prostate from the rectum, greatly minimizing the possibility of side effects. Graham received his medical degree from St. George’s University School of Medicine in Grenada, West Indies. He performed an internship in general surgery at Guthrie Clinic in Sayre, Pennsylvania. He performed residencies in radiation oncology at Northwestern University School of Medicine in Chicago and Eastern Virginia Medical School in Norfolk. He is board certified in radiation oncology by the American Board of Radiology. Graham is a member of the American Medical Association, the American Society of Therapeutic Radiation Oncology, the American Society of Clinical Oncology, the International Association for Hospice and Palliative Care, the Cyberknife Society and the Radiosurgery Society. 863-603-4717. 

LAKELAND REGIONAL HEALTH

Mohammad Elballat © Provided to The Ledger Mohammad Elballat

Mohammad Elballat specializes in pulmonology, critical care and sleep medicine. He is board certified in internal medicine, pulmonology and critical care. Elballat has experience in sleep apnea, insomnia, narcolepsy, parasomnias and managing complex surgical patients and critically ill neurosurgical patients. Elballat earned his medical degree in general medicine and surgery from Tanta University, Egypt. He completed his internal medicine residency at the University of Miami/JFK Consortium in West Palm Beach. Elballat completed his pulmonary critical care fellowship at the University of Tennessee Health Science Center in Memphis, Tennessee, and his sleep medicine fellowship at the University of South Florida in Tampa. Elballat cares for patients at our Grasslands Campus and the Medical Center.

Sydney Pate © Provided to The Ledger Sydney Pate

Sydney Pate recently joined Lakeland Regional Health as a surgical first assistant. She is a certified physician’s assistant who has extensive clinical experience in plastic surgery, general surgery, emergency medicine, internal medicine, pediatrics, family medicine, and OB/GYN. Pate earned her bachelor's in chemistry and master's in physician assistant studies from Butler University in Indianapolis. Pate sees patients at the Lakeland Regional Health Medical Center.

Lakeland Regional Health is one of 2022’s Digital Health Most Wired hospital and health systems, as announced by the College of Healthcare Information Management Executives. This is the eighth time that Lakeland Regional Health has earned the Most Wired recognition. Lakeland Regional Health Medical Center achieved Level 8 Acute recognition and Lakeland Regional Health ambulatory locations received Level 8 Ambulatory recognition. The CHIME Digital Health Most Wired program conducted an annual survey of more than 38,000 organizations to assess how effectively they apply core and advanced technologies into their clinical and business programs to Boost health and care in their communities.

NEMOURS LAKELAND

Azlyn Goff © Provided to The Ledger Azlyn Goff

Azlyn Goff is a pediatric orthopedic surgeon at Nemours Children’s Hospital, Florida in Orlando and Lakeland. In addition to English, Goff is fluent in Spanish. She joined Nemours Children’s Health in September after completing a pediatric orthopedic surgery fellowship at Vanderbilt University Medical Center in Nashville, Tennessee, where she was an assistant clinical professor in the Department of Pediatric Orthopedic Surgery. Goff earned her bachelor's in chemistry and biochemistry at Florida State University in Tallahassee and her Doctor of Medicine degree at New York Medical College in Valhalla, New York. She performed her orthopedic surgery residency at Westchester Medical Center in Valhalla, New York.

This article originally appeared on The Ledger: Medical people: News about medical professionals around Polk County

Mon, 05 Dec 2022 19:56:15 -0600 en-US text/html https://www.msn.com/en-us/health/medical/medical-people-news-about-medical-professionals-around-polk-county/ar-AA14XsrZ
Killexams : Vyne Medical Achieves HITRUST Risk-based, 2-year Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

Vyne Medical®, a leading provider of end-to-end health information exchange and electronic healthcare communication management, today announced their FastAttach®, Trace® Web Application (Hosted), and Refyne™ Denials Management systems have earned Certified status for information security by HITRUST

DUNWOODY, Ga., Nov. 28, 2022 /PRNewswire-PRWeb/ -- HITRUST® Risk-based, 2-year (r2) Certified status demonstrates that the organization's innovative systems have met key regulations and industry-defined requirements and are appropriately managing risk. This achievement places Vyne Medical in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.

"We welcome this certification by HITRUST as it demonstrates Vyne Medical's commitment to maintaining the industry's highest standards for data protection and information security," said Vyne CEO Steve Roberts. "Vyne remains committed to observing the industry's best practices for information risk management and compliance procedures, and we are delighted that Vyne Medical continues to be part of an elite group of organizations earning this certification."

"In today's ever-changing threat landscape, HITRUST is continually innovating to find new and creative approaches to address challenges," said Jeremy Huval, Chief Innovation Officer, HITRUST. Vyne Medical's HITRUST Risk-based, 2-year Certification is evidence that they are at the forefront of industry best practices for information risk management and compliance."

About Vyne Medical:
Vyne Medical is a recognized industry leader in end-to-end health information exchange and electronic healthcare communication management and is one of the largest CMS Certified Health Information Handlers (HIH). Vyne Medical's robust technology platforms facilitate the electronic capture, storage and submission of healthcare data in virtually any form – voice, fax, image, data or electronic document. Vyne Medical's solutions connect disconnected data to close gaps in documentation and Boost the continuum of care through a more complete and fully accessible patient record. Outcomes include improved financial strength, operational performance and patient experience.

The newly certified Trace solution is the flagship product of Vyne Medical's proven technology platform for effectively managing healthcare communication and facilitating the secure exchange of health information. And the newly certified Refyne Denials Management solution is the lead product for audits and authorizations management streamlining government audit workflows through the electronic submission of medical documentation.

More than 800 leading hospitals and health systems utilize Vyne Medical solutions to manage critical patient information that typically resides outside the electronic health record and leverage the data for improved financial performance, operational efficiency, and patient experience. For more information, visit https://vynemedical.com/.

Vyne Medical Media Contact:
Amy Mendoza Leonor
Vyne Corp
amy.leonor@vynedental.com

© 2022 Napa EA/MEDX, LLC. All rights reserved. All third-party trademarks and tradenames (including logos and icons) referenced are and remain the property of their respective owners.

Media Contact

Amy Mendoza Leonor, Vyne Medical, 256-269-1671, amy.leonor@vynedental.com

SOURCE Vyne Medical

Mon, 28 Nov 2022 00:01:00 -0600 en-US text/html https://www.yahoo.com/now/vyne-medical-achieves-hitrust-risk-140000561.html
Killexams : Moonshot Achieves ISO Certification of Information Security Management System No result found, try new keyword!Moonshot, a leading provider of IT services and staffing, announces today that it obtained ISO 27001 (ISO/IEC 27001) certification for the Information Security Management System (ISMS) in support of ... Tue, 06 Dec 2022 08:25:00 -0600 en-US text/html https://www.tmcnet.com/usubmit/-moonshot-achieves-iso-certification-information-security-management-system-/2022/12/06/9725569.htm Killexams : Nextech Receives ONC Health IT Cures Update Certification to Support Compliance with the 21st Century Cures Act

TAMPA, Fla., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nextech, the market leader in electronic health record (EHR) and practice management (PM) software for ophthalmology, dermatology, plastic surgery, and other specialty practices, has achieved the Office of the National Coordinator for Health Information Technology (ONC-Health IT) 2015 Edition Cures Update Health IT certification, which goes into effect in 2023. This includes the latest interoperability standards needed to support compliance with the 21st Century Cures Act information-sharing requirements.

"This certification demonstrates Nextech's commitment to our current and future clients that our products meet the complex technical requirements of the 21st Century Cures Act Final Rule," said Courtney Tesvich, VP of Regulatory and Compliance for Nextech. "The ONC certification ensures patients have seamless and secure access to their health information—essential functionality that we now provide without additional fees or upcharges to new and existing Nextech customers."

Nextech EHR products were tested and certified in October 2022 by Drummond Group LLC, an Authorized Certification Body (ACB). ONC-ACB approval certifies that Nextech software demonstrates the functionality eligible clinicians need to successfully participate in quality programs requiring certified EHR technology. With more than 20 years of testing experience across various industries, Drummond Group brings a high level of technical expertise. Since becoming an ONC-ACB in 2010, Drummond Group has conducted more than 3,000 health IT tests and certifications.

The 21st Century Cures Act legislation requires practices across all medical specialties, including those that currently do not take part in MIPS, to provide patients with access to their health records and comply with information blocking and operational flexibility requirements by December 31, 2022. All EHR vendors must have certified functionality available to provide patient health information (PHI) upon request. By October 2023, that compliance requirement will extend to the EHR to continue attestation for MIPS and to avoid penalties. For those not Cures Act compliant, the HHS Office of Inspector General (OIG) will issue civil monetary penalties that can even impact providers not using a certified EHR. Additionally, providers can be penalized under the information-blocking provisions of the ONC Cures Act final rule.

About This Certification

Nextech software is 2015 Edition Cures Update compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

Cures Update Certifications include:

Nextech EHR

Nextech 17 ONC–ACB Certification ID: 15.04.04.2051.Ntec.17.09.1.221121

Nextech with NewCropRx 17 ONC–ACB Certification ID: 15.04.04.2051.Next.17.08.1.221121

IntelleChartPRO

IntelleChartPRO 8 ONC–ACB Certification ID: 15.04.04.2051.Inte.08.01.0.221121

For more, visit: 

https://www.nextech.com/compliance/onc-health-it/nextech
https://www.nextech.com/compliance/onc-health-it/intellechart

About Nextech
Nextech is the complete EHR and practice management software provider for more than 11,000 physicians and 60,000 office staff in ophthalmology, dermatology, and plastic surgery specialties across the US. Since 1997, Nextech has focused on reducing costs and boosting productivity to drive efficiency, fuel growth, and simplify the delivery of excellent patient care for clients. Visit Nextech.com to learn more.

About Drummond Group LLC

Drummond Group LLC is a global software test and certification lab that serves a wide range of vertical industries. In healthcare, Drummond tests and certifies Controlled Substance Ordering Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS) software and processes, and Electronic Health Records (EHRs) – designating the trusted test lab as the only third-party certifier of all three initiatives designed to move the industry toward a digital future. Drummond was founded in 1999 and is an ONC-Accredited Certification Body (ACB) and an Authorized Test Lab (ATL) and continues to build on its deep experience and expertise to deliver reliable and cost-effective services. For more information, please visit http://www.drummondgroup.com.

Chris Farrell
VP, Marketing
(813) 998-4229


© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Tue, 29 Nov 2022 00:10:00 -0600 text/html https://www.benzinga.com/pressreleases/22/11/g29889623/nextech-receives-onc-health-it-cures-update-certification-to-support-compliance-with-the-21st-cent
Killexams : Mississippi medical marijuana patients, professionals on the look out for scams and other complications Some patients who need the treatment are discovering the complications of the process to obtain a medical marijuana card. © Provided by Biloxi-Gulfport WLOX Some patients who need the treatment are discovering the complications of the process to obtain a medical marijuana card.

BILOXI, Miss. (WLOX) - It’s been almost a full year since the sale of medical marijuana was approved in Mississippi. Although the product still isn’t available for purchase, some patients who need the treatment are discovering the complications of the process to obtain a medical marijuana card. Scammers are also looking to take advantage of the new industry.

The medical cannabis program in Mississippi requires patients have at least one of the listed qualifying conditions to purchase the product. Long Beach resident Tommy Goldman suffers from multiple conditions needed for the treatment.

“I have chronic pain in my knees, and I’ve been diagnosed recently with Parkinson’s,” said Goldman.

In May, Kevin Webster, the owner of the group Ride to Wellness, said in a WLOX report he would help patients like Tommy Goldman through the process of getting medical marijuana for a fee of $199.

In September, Goldman took Webster up on his offer. After paying over the phone, he says Webster told him to meet at a Gulfport hotel to fill out the needed paper work for a medical marijuana card. When Goldman got there, no one representing Ride to Wellness was to be found, and his attempts to reach Webster have been unsuccessful.

“I tried calling him and haven’t heard anything from him since I gave him the money,” said Goldman.

Ride to Wellness has multiple Facebook pages saying it offers service in several states. No post has been made on its Mississippi page since July. The website listed on the Facebook pages isn’t an active website.

WLOX tried calling the numbers listed for Ride to Wellness and left messages, but no one from the organization returned the calls.

President of the Mississippi Better Business Bureau John O’Hara says there are complaints on Facebook about the group in Mississippi and Oklahoma. He says it’s always a good idea to research any company before paying money for a service up front, especially a newer industry like medical marijuana.

“This is taking advantage of Mississippi had just passed legalizing medical marijuana, so everybody is learning as we go through this,” O’Hara said.

The patients aren’t the only ones having to learn. Dr. Philip Levin is one of only 122 practitioners currently certified by the State Health Department to recommend the issue of medical marijuana cards in Mississippi.

“Once I started studying cannabis, I was blown away with how much good it does,” said Levin. “Once I found out how natural it was, how helpful and how harmless, I really wanted to help my patients.”

Levin says the time commitment to see patients wanting a medical marijuana card is holding up practitioners’ interest to get certified.

“It’s not an easy procedure,” said Levin. “You have to check the medical records to make sure they qualify, you have to do a drug screen, a PMP, a physical exam, do medical records and fill out the form. I also will supply the patient another 5-10 minutes of information. So how can you run a clinic and spend 25 minutes on talking to the patients to get them certified just for the little bit of money you’re going to make off of it?”

Cultivators have been preparing for months to send out their products to approved dispensaries around the state. Levin says for customers to actually be available to buy those products more practitioners need to be certified. At the time this story was published about 1,000 patients were approved to buy medical marijuana in the state.

“The main bottleneck right now is the certification,” said Levin. “The growers have plenty of product, they’ve been very successful growing and the dispensaries are eager to get the product to sell, but that in between step, the companies that are supposed to be certifying the product is having technical difficulties and that’s why we don’t have any product out yet.”

If you’re interested in medical marijuana and want to avoid any complications, Levin says the first step to take should be talking to a trusted family doctor.

“My recommendation would be to have your own private physician either do it or refer you to someone you know and trust like you would with any specialist,” said Levin.

Levin expects the first products to be available for purchase in early 2023. It can’t get here quick enough for Tommy Goldman who just wants relief for his pain.

“I’m going to be happy when I get it because it’s going to be legal. That’s I all I want, for it to be legal,” said Goldman.

You can see a list of medical practitioners currently certified to issue medical marijuana cards in Mississippi here: https://www.mscannapatient.com/medical-marijuana-doctors-near-me/

Want more WLOX news in your inbox? Click here to subscribe to our newsletter.

Mon, 05 Dec 2022 12:32:43 -0600 en-US text/html https://www.msn.com/en-us/health/medical/mississippi-medical-marijuana-patients-professionals-on-the-look-out-for-scams-and-other-complications/ar-AA14WXEx
Killexams : Medical PP Infusion Bottle Market 2023 In-Depth Insights and Business Scenario, by Analysts Certification 2028 | Newst 93 Pages Report

The MarketWatch News Department was not involved in the creation of this content.

Medical PP Infusion Bottle Market Report is a large project with critical infrastructure designed to support complex access efficiently, scalable applications and integrates with large data generating companies such as SSY Group Limited, Gil Pack, Dai Han Pharm, Ilhaplast, Fresenius KABI. Using Medical PP Infusion Bottle Market is opening new frontiers across in the Medical Devices and Consumables industry. With the ability to manage things, the Medical PP Infusion Bottle market has a lot of power to change parts of the form (Below 50 ml, 50 ml-100 ml, Above 100 ml), application (Hospital, Clinic, Others). The Medical PP Infusion Bottle industry report provides research that includes market share of Medical PP Infusion Bottle size and business strategies across the globe at the regional and national levels, development of partnerships, providing detailed analysis, return to 2022 Medical PP Infusion Bottle market up-to- day market share.

Medical PP Infusion Bottle Market - Covid-19 Impact and Recovery Analysis:

We have been tracking the direct impact of COVID-19 on this market, as well as the indirect impact from other industries. This report analyzes the impact of the pandemic on the Medical PP Infusion Bottle market from a Global and Regional perspective. The report outlines the market size, market characteristics, and market growth for Medical PP Infusion Bottle industry, categorized by type, application, and consumer sector. In addition, it provides a comprehensive analysis of aspects involved in market development before and after the Covid-19 pandemic. Report also conducted a PESTEL analysis in the industry to study key influencers and barriers to entry.

Final Report will add the analysis of the impact of COVID-19 on this industry.

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT - REQUEST SAMPLE

It also provides accurate information and cutting-edge analysis that is necessary to formulate an ideal business plan, and to define the right path for rapid growth for all involved industry players. With this information, stakeholders will be more capable of developing new strategies, which focus on market opportunities that will benefit them, making their business endeavours profitable in the process.

Medical PP Infusion Bottle Market - Competitive and Segmentation Analysis:

This Medical PP Infusion Bottle Market report offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2017-2022. The report also includes company description, major business, Medical PP Infusion Bottle product introduction, accurate developments and Medical PP Infusion Bottle sales by region, type, application and by sales channel.

The major players covered in the Medical PP Infusion Bottle market report are:

● SSY Group Limited ● Gil Pack ● Dai Han Pharm ● Ilhaplast ● Fresenius KABI

Get a trial PDF of report - https://www.360marketupdates.com/enquiry/request-sample/20943604

Short Summery About Medical PP Infusion Bottle Market:

The Global Medical PP Infusion Bottle market is anticipated to rise at a considerable rate during the forecast period, between 2022 and 2028. In 2022, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

As the global economy mends, the 2022 growth of Medical PP Infusion Bottle will have significant change from previous year. According to our latest study, the global Medical PP Infusion Bottle market size is USD million in 2022 from USD million in 2022, with a change of % between 2022 and 2022. The global Medical PP Infusion Bottle market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Medical PP Infusion Bottle market is expected at value of USD million in 2022 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Medical PP Infusion Bottle market, reaching USD million by the year 2028. As for the Europe Medical PP Infusion Bottle landscape, Germany is projected to reach USD million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Medical PP Infusion Bottle players cover SSY Group Limited, Gil Pack, Dai Han Pharm, and Ilhaplast, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical PP Infusion Bottle market by product type, application, key manufacturers and key regions and countries.

Report further studies the market development status and future Medical PP Infusion Bottle Market trend across the world. Also, it splits Medical PP Infusion Bottle market Segmentation by Type and by Applications to fully and deeply research and reveal market profile and prospects.

On the basis of product typethis report displays the production, revenue, price, market share and growth rate of each type, primarily split into:

● Below 50 ml ● 50 ml-100 ml ● Above 100 ml

On the basis of the end users/applicationsthis report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including:

● Hospital ● Clinic ● Others

Get a trial Copy of the Medical PP Infusion Bottle Market Report 2022

Medical PP Infusion Bottle Market - Regional Analysis:

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Medical PP Infusion Bottle in these regions, from 2015 to 2028, covering

● North America (United States, Canada and Mexico) ● Europe (Germany, UK, France, Italy, Russia and Turkey etc.) ● Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam) ● South America (Brazil, Argentina, Columbia etc.) ● Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Some of the key questions answered in this report:

● What is the global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) sales value, production value, consumption value, import and export of Medical PP Infusion Bottle? ● Who are the global key manufacturers of the Medical PP Infusion Bottle Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)? ● What are the Medical PP Infusion Bottle market opportunities and threats faced by the vendors in the global Medical PP Infusion Bottle Industry? ● Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application? ● What focused approach and constraints are holding the Medical PP Infusion Bottle market? ● What are the different sales, marketing, and distribution channels in the global industry? ● What are the upstream raw materials and manufacturing equipment of Medical PP Infusion Bottle along with the manufacturing process of Medical PP Infusion Bottle? ● What are the key market trends impacting the growth of the Medical PP Infusion Bottle market? ● Economic impact on the Medical PP Infusion Bottle industry and development trend of the Medical PP Infusion Bottle industry. ● What are the market opportunities, market risk, and market overview of the Medical PP Infusion Bottle market? ● What are the key drivers, restraints, opportunities, and challenges of the Medical PP Infusion Bottle market, and how they are expected to impact the market? ● What is the Medical PP Infusion Bottle market size at the regional and country-level?

Our research analysts will help you to get customized details for your report, which can be modified in terms of a specific region, application or any statistical details. In addition, we are always willing to comply with the study, which triangulated with your own data to make the market research more comprehensive in your perspective.

Inquire more and share questions if any before the purchase on this report at -https://www.360marketupdates.com/enquiry/pre-order-enquiry/20943604

Detailed TOC of Global Medical PP Infusion Bottle Market Research Report 2022

1 Medical PP Infusion Bottle Market Overview

1.1 Product Overview and Scope of Medical PP Infusion Bottle
1.2 Medical PP Infusion Bottle Segment by Type
1.2.1 Global Medical PP Infusion Bottle Market Size Growth Rate Analysis by Type 2022 VS 2028
1.3 Medical PP Infusion Bottle Segment by Application
1.3.1 Global Medical PP Infusion Bottle Consumption Comparison by Application: 2022 VS 2028
1.4 Global Market Growth Prospects
1.4.1 Global Medical PP Infusion Bottle Revenue Estimates and Forecasts (2017-2028)
1.4.2 Global Medical PP Infusion Bottle Production Capacity Estimates and Forecasts (2017-2028)
1.4.3 Global Medical PP Infusion Bottle Production Estimates and Forecasts (2017-2028)
1.5 Global Market Size by Region
1.5.1 Global Medical PP Infusion Bottle Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
1.5.2 North America Medical PP Infusion Bottle Estimates and Forecasts (2017-2028)
1.5.3 Europe Medical PP Infusion Bottle Estimates and Forecasts (2017-2028)
1.5.4 China Medical PP Infusion Bottle Estimates and Forecasts (2017-2028)
1.5.5 Japan Medical PP Infusion Bottle Estimates and Forecasts (2017-2028)

2 Market Competition by Manufacturers
2.1 Global Medical PP Infusion Bottle Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Medical PP Infusion Bottle Revenue Market Share by Manufacturers (2017-2022)
2.3 Medical PP Infusion Bottle Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Medical PP Infusion Bottle Average Price by Manufacturers (2017-2022)
2.5 Manufacturers Medical PP Infusion Bottle Production Sites, Area Served, Product Types
2.6 Medical PP Infusion Bottle Market Competitive Situation and Trends
2.6.1 Medical PP Infusion Bottle Market Concentration Rate
2.6.2 Global 5 and 10 Largest Medical PP Infusion Bottle Players Market Share by Revenue
2.6.3 Mergers and Acquisitions, Expansion

3 Production Capacity by Region
3.1 Global Production Capacity of Medical PP Infusion Bottle Market Share by Region (2017-2022)
3.2 Global Medical PP Infusion Bottle Revenue Market Share by Region (2017-2022)
3.3 Global Medical PP Infusion Bottle Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 North America Medical PP Infusion Bottle Production
3.4.1 North America Medical PP Infusion Bottle Production Growth Rate (2017-2022)
3.4.2 North America Medical PP Infusion Bottle Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Medical PP Infusion Bottle Production
3.5.1 Europe Medical PP Infusion Bottle Production Growth Rate (2017-2022)
3.5.2 Europe Medical PP Infusion Bottle Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 China Medical PP Infusion Bottle Production
3.6.1 China Medical PP Infusion Bottle Production Growth Rate (2017-2022)
3.6.2 China Medical PP Infusion Bottle Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Japan Medical PP Infusion Bottle Production
3.7.1 Japan Medical PP Infusion Bottle Production Growth Rate (2017-2022)
3.7.2 Japan Medical PP Infusion Bottle Production Capacity, Revenue, Price and Gross Margin (2017-2022)

4 Global Medical PP Infusion Bottle Consumption by Region
4.1 Global Medical PP Infusion Bottle Consumption by Region
4.1.1 Global Medical PP Infusion Bottle Consumption by Region
4.1.2 Global Medical PP Infusion Bottle Consumption Market Share by Region
4.2 North America
4.2.1 North America Medical PP Infusion Bottle Consumption by Country
4.2.2 United States
4.2.3 Canada
4.3 Europe
4.3.1 Europe Medical PP Infusion Bottle Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Medical PP Infusion Bottle Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 China Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Medical PP Infusion Bottle Consumption by Country
4.5.2 Mexico
4.5.3 Brazil

Get a trial Copy of the Medical PP Infusion Bottle Market Report 2022

5 Segment by Type
5.1 Global Medical PP Infusion Bottle Production Market Share by Type (2017-2022)
5.2 Global Medical PP Infusion Bottle Revenue Market Share by Type (2017-2022)
5.3 Global Medical PP Infusion Bottle Price by Type (2017-2022)
6 Segment by Application
6.1 Global Medical PP Infusion Bottle Production Market Share by Application (2017-2022)
6.2 Global Medical PP Infusion Bottle Revenue Market Share by Application (2017-2022)
6.3 Global Medical PP Infusion Bottle Price by Application (2017-2022)

7 Key Companies Profiled
7.1 Company
7.1.1 Medical PP Infusion Bottle Corporation Information
7.1.2 Medical PP Infusion Bottle Product Portfolio
7.1. CMedical PP Infusion Bottle Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.1.4 Company’s Main Business and Markets Served
7.1.5 Company’s accurate Developments/Updates

8 Medical PP Infusion Bottle Manufacturing Cost Analysis
8.1 Medical PP Infusion Bottle Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Medical PP Infusion Bottle
8.4 Medical PP Infusion Bottle Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Medical PP Infusion Bottle Distributors List
9.3 Medical PP Infusion Bottle Customers

10 Market Dynamics
10.1 Medical PP Infusion Bottle Industry Trends
10.2 Medical PP Infusion Bottle Market Drivers
10.3 Medical PP Infusion Bottle Market Challenges
10.4 Medical PP Infusion Bottle Market Restraints

11 Production and Supply Forecast
11.1 Global Forecasted Production of Medical PP Infusion Bottle by Region (2023-2028)
11.2 North America Medical PP Infusion Bottle Production, Revenue Forecast (2023-2028)
11.3 Europe Medical PP Infusion Bottle Production, Revenue Forecast (2023-2028)
11.4 China Medical PP Infusion Bottle Production, Revenue Forecast (2023-2028)
11.5 Japan Medical PP Infusion Bottle Production, Revenue Forecast (2023-2028)

12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Medical PP Infusion Bottle
12.2 North America Forecasted Consumption of Medical PP Infusion Bottle by Country
12.3 Europe Market Forecasted Consumption of Medical PP Infusion Bottle by Country
12.4 Asia Pacific Market Forecasted Consumption of Medical PP Infusion Bottle by Region
12.5 Latin America Forecasted Consumption of Medical PP Infusion Bottle by Country

13 Forecast by Type and by Application (2023-2028)
13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
13.1.1 Global Forecasted Production of Medical PP Infusion Bottle by Type (2023-2028)
13.1.2 Global Forecasted Revenue of Medical PP Infusion Bottle by Type (2023-2028)
13.1.3 Global Forecasted Price of Medical PP Infusion Bottle by Type (2023-2028)
13.2 Global Forecasted Consumption of Medical PP Infusion Bottle by Application (2023-2028)
13.2.1 Global Forecasted Production of Medical PP Infusion Bottle by Application (2023-2028)
13.2.2 Global Forecasted Revenue of Medical PP Infusion Bottle by Application (2023-2028)
13.2.3 Global Forecasted Price of Medical PP Infusion Bottle by Application (2023-2028)

14 Research Finding and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

Continued….

Purchase this report (Price 3660 USD for a single-user license) -https://www.360marketupdates.com/purchase/20943604

About Us:

360 Market Updates is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Market Updates, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us:
Web:https://360marketupdates.com
Email: sales@360marketupdates.com
Organization: 360 Market Updates
Phone: +44 20 3239 8187/ +14242530807

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Medical PP Infusion Bottle Market 2023 In-Depth Insights and Business Scenario, by Analysts Certification 2028 | Newst 93 Pages Report

COMTEX_420274366/2598/2022-12-05T23:35:25

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Mon, 05 Dec 2022 13:35:00 -0600 en-US text/html https://www.marketwatch.com/press-release/medical-pp-infusion-bottle-market-2023-in-depth-insights-and-business-scenario-by-analysts-certification-2028-newst-93-pages-report-2022-12-05
Killexams : Hospitals earn advanced certification

MORGANTOWN — Mon Health Stonewall Jackson Memorial Hospital, Mon Health

Medical Center, and Mon Health Preston Memorial Hospital have earned advanced certification in stroke care, affirming their readiness to handle strokes and stroke related medical problems.

Mon Health Stonewall Jackson Memorial Hospital was recently awarded the DNV Acute Stroke Ready Certification in October 2022. The certification is derived from evidence-based standards set forth by the Brain Attack Coalition and the American Stroke Association and affirms that the hospital addresses the initial diagnosis, treatment, and when necessary, facilitates quick transfer to a specialized stroke center with a higher spectrum of stroke care.

“Being recognized as an Acute Stroke Ready Center is a combination of the right equipment, personnel, and training to assess, identify, and treat strokes quickly. This includes the ability to efficiently transfer patients in the instances they require treatment beyond our capabilities,” said Morgan Norman, Trauma and Stroke Program Manager at Mon Health Stonewall Jackson Memorial Hospital.

Mon Health Medical Center and Mon Health Preston Memorial Hospital have been awarded The Joint Commission’s Gold Seal of Approval® for Acute Stroke Ready Certification by demonstrating continuous compliance with its performance standards. The Gold Seal is a symbol of quality that reflects a healthcare organization’s commitment to providing safe and quality patient care.

“This certification lets our community know that we have the resources and commitment to provide the best possible stroke care,” said Briana Bishop, Sepsis and Stroke Coordinator at Mon Health Medical Center.

“Achieving this validates the tremendous efforts we have put into this program, ensuring the health and safety of our patients.”

Mon Health Preston Memorial Hospital also recently earned the American Stroke Association’s Heart-Check mark for the Acute Stroke Ready Certification.

“We are extremely proud of our teams and their commitment to providing quality and safe stroke care to our patients,” said Cindy Likens, Stroke Coordinator at Mon Health Preston Memorial Hospital.

According to the American Stroke Association, stroke is the leading cause of death, killing 130,000 people each year, and is a leading cause of serious, long-term adult disability. Because stroke or “brain attack” effects blood flow to the brain, rapid and effective treatment can save lives and provide the best chance of limiting the extent of long-term damage.

To learn more about Mon Health System, visit MonHealth.com. For more information on the Acute Stroke Ready Certification from DNV, visit DNV’s website. For more information on the Acute Stroke Ready Certification from The Joint Commission, visit The Joint Commission website.

Today's breaking news and more in your inbox

Sun, 27 Nov 2022 18:47:00 -0600 en-US text/html https://www.theintermountain.com/news/communities/2022/11/hospitals-earn-advanced-certification/
Killexams : Medical science program expands; more hands-on training

FORT WAYNE — The Parkview Medical Laboratory Science Program will soon train twice as many people in a newly renovated student lab, helping to meet rapidly growing demand in a lesser-known health care field.

Renovations to the program’s space, including the student lab, classroom and offices in the lower level of Parkview Hospital Randallia on East State Street, were completed in November. The updated accommodations will allow the program to admit up to 20 students per year, more than doubling its previous capacity of nine students per year.

In addition to expanding capacity, Parkview’s program is transitioning from a 10-month “rotation-based” model to a 12-month “student-based” model. Previously, students completed lab training through clinical rotations while their lecture schedule may have covered different topics.

Under the new student-based model, students will complete labs and lectures on the same subjects simultaneously, with the majority of their training taking place in the new student lab. No active patient samples are processed in the student lab, but it features equipment similar to that of an active lab, giving students realistic, hands-on practice on a smaller scale. In the final 10 weeks of their program, students will complete their clinical rotations with lab departments throughout Parkview to learn and work under the supervision of a credentialed lab scientist.

“We are thrilled to expand and enhance our program so we can offer even more people the opportunity to receive hands-on training and experience,” said Brian Goff, program director, Parkview Medical Laboratory Science Program. “Medical lab science is often called the ‘stealth medical degree’ because most people think of becoming a doctor, nurse or pharmacist instead. Now is an especially exciting time to enter this lesser-known career field as we see incredible advances in science and technology, along with rapidly growing demand for more highly trained individuals.”

Established in 1956, the Parkview Medical Laboratory Science Program is accredited by the National Accrediting Agency for Clinical Laboratory Sciences. The focus of Parkview’s program is to prepare students to pass their exams for national certification, which is required by most employers.

In the last three years, the Parkview Medical Laboratory Science Program has maintained a 100% pass rate for national certification. Currently, the program also has a 100% job placement rate. Students are being hired immediately upon completion of their program and certification, which is proof of the increasingly high demand for professionals in this field.

“About 70% of medical decisions are based on lab results, so we have a significant impact on patient care, but we are often not seen by the patients or providers,” said Allegra McMillen, clinical lab school educator, Parkview Medical Laboratory Science Program. “This career is ideal for someone who maybe has an introverted, puzzle-loving personality, but wants to help patients and providers get the information they need.”

“I didn’t know medical lab science was a degree option even though I had been deeply steeped in science classes throughout high school and college,” said Catherine Egley, another clinical lab school educator. “We are going to see open positions in our field for the foreseeable future, making this a lucrative career option for people who want to work in science or health care but don’t necessarily want that daily interaction with patients.”

The Parkview Medical Laboratory Science Program also offers students some flexibility as to when they enroll. A student could complete Parkview’s program during the final year of their bachelor’s degree or they could complete their bachelor’s degree before starting Parkview’s program.

More details on admission requirements can be found on the program’s website, parkview.com/careers/medical-laboratory-science-program/about-our-program.

Mon, 05 Dec 2022 13:59:00 -0600 en text/html https://www.kpcnews.com/thestar/article_0bc92322-b3a3-5ad8-b366-596f021b9555.html
OCN exam dump and training guide direct download
Training Exams List